VENBIO SELECT ADVISOR Overview
Venbio Select Advisor Llc is a hedge fund that manages 503.9 MM dollars in regulatory AUM and has 10 employees, of which 5 perform investment advisory functions.
The manager's has disclosed holdings from 12/31/14 to 06/30/20. The fund's latest filing disclosed 5BN in positions, representing 1004% of the manager's regulatory AUM.
The manager's has disclosed holdings from 12/31/14 to 06/30/20. The fund's latest filing disclosed 5BN in positions, representing 1004% of the manager's regulatory AUM.
VENBIO SELECT ADVISOR StockAlpha
| Top 25% |
3yr StockAlpha
Register for more...
Fundamental & Technical Factor Exposure
VENBIO SELECT ADVISOR Since Last Filing Return Details
| Ticker | Size | Sector | Stock Move | StockAlpha Attribution | Days to Liquidate | Trade Crowdedness | ||
|---|---|---|---|---|---|---|---|---|
| IMMU | 18.39% | Health | 141% | 24.96% | 6 | 7% | ||
| MRTX | 9.68% | Health | 42.03% | 3.66% | 10 | 5% | ||
|
Get the Full Report |
||||||||
FEATURED IN
VENBIO SELECT ADVISOR Founders and Key Employees
| Name | Title | In Position Since |
|---|
| Robert Adelman | Manager | January-2013 |
| Corey S. Goodman | Manager | January-2013 |
| Paul A. Brooke | Manager | January-2013 |
| Behzad Aghazadeh | Portfolio Manager | July-2011 |
| Scott A. Epstein | Chief Financial Officer And Chief Compliance Officer | June-2014 |
VENBIO SELECT ADVISOR Brokers, Custodians, Auditors and Administrators
| Type | Company |
|---|
| Administrator | Pro |
| Administrator | Pro |
| Auditor | Pro |
| Auditor | Pro |
| Custodian | Pro |
| Custodian | Pro |
| Custodian | Pro |
| Prime Broker | Pro |
VENBIO SELECT ADVISOR Investment Strategy
Methods of Analysis, Investment Strategies and Risk of Loss
A. Methods of Analysis and Investment Strategies
Investment Objective:
The Clients’ objective is to achieve attractive returns with moderate risk. The Clients invest primarily in the equity, debt and associated derivatives of companies operating in the life sciences sector and related industries. However, the Clients’ investment program is speculative and entails risk, and there can be no assurance that the investment objective of the Clients will be achieved.
The Clients will generally invest in securities of a broad range of life science companies that VBSA
believes can occupy leading positions in their markets and have the potential to return multiples on
4
Part 2A of ADV:
venBio Select Advisor LLC Brochure
invested capital. VBSA anticipates that the primary emphasis will be on companies engaged in the key sectors of the life sciences industry: biotechn...
Get the Full Report
A. Methods of Analysis and Investment Strategies
Investment Objective:
The Clients’ objective is to achieve attractive returns with moderate risk. The Clients invest primarily in the equity, debt and associated derivatives of companies operating in the life sciences sector and related industries. However, the Clients’ investment program is speculative and entails risk, and there can be no assurance that the investment objective of the Clients will be achieved.
The Clients will generally invest in securities of a broad range of life science companies that VBSA
believes can occupy leading positions in their markets and have the potential to return multiples on
4
Part 2A of ADV:
venBio Select Advisor LLC Brochure
invested capital. VBSA anticipates that the primary emphasis will be on companies engaged in the key sectors of the life sciences industry: biotechn...
Get the Full Report
VENBIO SELECT ADVISOR Portfolio Concentration
VENBIO SELECT ADVISOR Location
1700 OWENS STREET, SUITE 595
SAN FRANCISCO, California
UNITED STATES, 94158
SAN FRANCISCO, California
UNITED STATES, 94158
VENBIO SELECT ADVISOR Contact Information
Phone Number: 415-800-0800
Fax Number: 650-244-9070
Website: http://www.venbio.com
Fax Number: 650-244-9070
Website: http://www.venbio.com
READ RECENT SYMMETRIC REPORTS
Disclaimer
The information contained herein: (1) is proprietary to Symmetric and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Symmetric nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance and skill metrics are no guarantee of future results. "Symmetric," "Symmetric.io" and the Symmetric logo are marks of Symmetric, Inc. Read our privacy policy here. Read our terms of use here
